4.3 Article

Gene Therapy for ALI/ARDS

Journal

CRITICAL CARE CLINICS
Volume 27, Issue 3, Pages 705-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccc.2011.04.002

Keywords

Gene therapy; Acute lung injury; Viral vectors; Nonviral vectors

Funding

  1. NIH [HL81148, HL92801, EB9903, GM94228]

Ask authors/readers for more resources

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by acute respiratory failure and are associated with diverse disorders. Gene therapy is a potentially powerful approach to treat diseases related to ALI/ARDS, and numerous viral and nonviral methods for gene delivery to the lung have been developed. Discussed are recent advances in the development of more efficient viral and nonviral gene transfer systems, and the current status of gene therapy applied to ALI/ARDS-associated pulmonary diseases is reviewed. With the development of more efficient gene therapy vectors, gene therapy is a promising strategy for clinical application.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available